Vontobel Holding Ltd. Buys 4,538 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Vontobel Holding Ltd. lifted its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 6.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 74,658 shares of the company’s stock after buying an additional 4,538 shares during the period. Vontobel Holding Ltd. owned about 0.08% of Acadia Healthcare worth $5,805,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in ACHC. Vanguard Group Inc. raised its position in Acadia Healthcare by 0.3% in the third quarter. Vanguard Group Inc. now owns 8,831,131 shares of the company’s stock worth $620,917,000 after purchasing an additional 26,379 shares in the last quarter. Wellington Management Group LLP raised its position in Acadia Healthcare by 2.1% in the third quarter. Wellington Management Group LLP now owns 7,537,922 shares of the company’s stock worth $529,991,000 after purchasing an additional 152,783 shares in the last quarter. William Blair Investment Management LLC raised its position in Acadia Healthcare by 0.3% in the third quarter. William Blair Investment Management LLC now owns 3,058,916 shares of the company’s stock worth $215,072,000 after purchasing an additional 10,062 shares in the last quarter. State Street Corp raised its position in Acadia Healthcare by 0.9% in the second quarter. State Street Corp now owns 2,563,638 shares of the company’s stock worth $204,168,000 after purchasing an additional 22,019 shares in the last quarter. Finally, Durable Capital Partners LP raised its position in Acadia Healthcare by 30.8% in the fourth quarter. Durable Capital Partners LP now owns 1,941,595 shares of the company’s stock worth $159,832,000 after purchasing an additional 457,687 shares in the last quarter.

Analyst Ratings Changes

Several research firms recently issued reports on ACHC. Royal Bank of Canada reissued an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a research report on Monday, March 4th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a report on Tuesday, March 5th. Mizuho raised their price objective on shares of Acadia Healthcare from $77.00 to $84.00 and gave the stock a “neutral” rating in a report on Wednesday, March 6th. TD Cowen raised their price objective on shares of Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. Finally, Barclays began coverage on shares of Acadia Healthcare in a report on Wednesday, March 6th. They set an “overweight” rating and a $100.00 price objective for the company. One research analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $91.22.

Insider Buying and Selling at Acadia Healthcare

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the firm’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now directly owns 46,074 shares of the company’s stock, valued at $3,934,258.86. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 2.80% of the company’s stock.

Acadia Healthcare Price Performance

ACHC opened at $70.25 on Thursday. Acadia Healthcare Company, Inc. has a one year low of $66.49 and a one year high of $87.77. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.67 and a quick ratio of 0.67. The company’s 50 day simple moving average is $79.62 and its 200-day simple moving average is $77.60. The stock has a market capitalization of $6.49 billion, a P/E ratio of -280.99, a price-to-earnings-growth ratio of 2.16 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, February 28th. The company reported $0.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.80 by $0.05. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The firm had revenue of $742.80 million for the quarter, compared to analysts’ expectations of $727.60 million. During the same period last year, the firm earned $0.70 earnings per share. The business’s revenue for the quarter was up 10.0% on a year-over-year basis. Sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.57 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.